214557-51-4 Usage
Structure
Cyclic ether with a spiro arrangement
The molecule consists of a seven-membered ring and a six-membered ring fused together, forming a spiro structure.
Functional groups
Ketone and methyl group
The molecule contains a ketone functional group (C=O) and a methyl group (CH3) attached to the seven-membered ring.
Application
Synthesis of organic compounds
It is commonly used in the synthesis of various organic compounds.
Industry applications
Pharmaceutical and fragrance industries
The compound has applications in both the pharmaceutical and fragrance industries.
Safety
Reactivity and potential hazards
It is important to handle 1,4-Dioxaspiro[4.4]nonan-6-one, 7-methyl- with care and follow proper safety protocols due to its reactivity and potential hazards.
Appearance
Not specified in the material provided
The appearance of the compound (e.g., color, state) is not mentioned in the given information.
Solubility
Not specified in the material provided
The solubility of the compound in various solvents is not mentioned in the given information.
Stability
Not specified in the material provided
The stability of the compound under different conditions (e.g., temperature, pressure) is not mentioned in the given information.
Melting or boiling point
Not specified in the material provided
The melting or boiling point of the compound is not mentioned in the given information.
Check Digit Verification of cas no
The CAS Registry Mumber 214557-51-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,5,5 and 7 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 214557-51:
(8*2)+(7*1)+(6*4)+(5*5)+(4*5)+(3*7)+(2*5)+(1*1)=124
124 % 10 = 4
So 214557-51-4 is a valid CAS Registry Number.
214557-51-4Relevant articles and documents
Synthesis of the trinervitane ring system
Dauben, William G.,Lorenz, Klaus L.,Dean, Daniel W.,Shapiro, Gideon,Farkas, Imre
, p. 7079 - 7082 (1998)
The synthesis of the basic tricyclic nucleus of the trinervitane diterpenes by means of the Robinson annelation and McMurry coupling is described.
SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE
-
Page/Page column 204, (2020/12/11)
The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.
